Literature DB >> 26306418

Dispensing good sleep health behaviours not pills--a cluster-randomized controlled trial to test the feasibility and efficacy of pharmacist-provided brief behavioural treatment for insomnia.

Joanne M Fuller, Keith K Wong, Camilla Hoyos, Ines Krass, Bandana Saini.   

Abstract

Behavioural therapies are recommended as the first-line treatment of insomnia; however, sedatives and hypnotics constitute the main treatment modality used in primary care. Community pharmacies provide a unique conduit for identifying and providing appropriate treatment for those with insomnia either purchasing prescription sedatives or seeking over-the-counter treatments. A feasibility study using a cluster-randomized controlled trial, testing the efficacy of trained pharmacists providing behavioural interventions such as stimulus control and sleep restriction to patients with insomnia, in improving insomnia severity was conducted. The intervention involved three pharmacy visits (baseline, 1 and 3 months follow-up). The control group received usual care and information sheets on insomnia. The primary outcome was the Insomnia Severity Index. Twelve community pharmacists (five control, seven intervention) in New South Wales, Australia were recruited and trained. These pharmacists, in turn, recruited 46 patients (22 control, 24 intervention (mean age 53.7 ± 18.4, 72% females) and delivered a brief behavioural therapy intervention. The overall decrease in Insomnia Severity Index from baseline to the 3-month follow-up in the intervention group, n = 17 (7.6 ± 4.3 points), was significantly greater than for the control group, n = 19 (2.9 ± 8.8 points) (mean difference 4.6, 95% confidence interval: 0.005-9.2, P = 0.05). However, when the effect of clustering was taken into account using a mixed-effects model, the estimated difference in Insomnia Severity Index (change from baseline to visit 3) between the intervention and control groups was not significant (group difference in Insomnia Severity Index change = 3.78, 95% confidence interval: -0.81 to 8.37, P = 0.11; intracluster correlation = 0.18). The study highlights the use of a novel venue to deliver brief behavioural therapies for insomnia using trained non-psychologist health professionals. Although, when cluster effect was taken into account, the difference in Insomnia Severity Index reduction between the intervention versus control groups was non-significant, the results highlight that reductions in insomnia severity can be gained using trained pharmacists providing brief behavioural interventions. Future research in this area is warranted, with appropriately sized studies using the conventional, robust randomized trial design.
© 2015 The Authors. Journal of Sleep Research published by John Wiley & Sons Ltd on behalf of European Sleep Research Society.

Entities:  

Mesh:

Year:  2016        PMID: 26306418     DOI: 10.1111/jsr.12328

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  8 in total

1.  The Promise of Digital CBT-I.

Authors:  Christopher L Drake
Journal:  Sleep       Date:  2016-01-01       Impact factor: 5.849

2.  Brief Behavioral Treatment for Insomnia: A Meta-Analysis.

Authors:  Misol Kwon; Jia Wang; Gregory Wilding; Suzanne S Dickerson; Grace E Dean
Journal:  Behav Sleep Med       Date:  2021-10-10       Impact factor: 3.492

3.  Community pharmacy interventions for health promotion: effects on professional practice and health outcomes.

Authors:  Liz Steed; Ratna Sohanpal; Adam Todd; Vichithranie W Madurasinghe; Carol Rivas; Elizabeth A Edwards; Carolyn D Summerbell; Stephanie Jc Taylor; R T Walton
Journal:  Cochrane Database Syst Rev       Date:  2019-12-06

4.  Patterns of concomitant prescription, over-the-counter and natural sleep aid use over a 12-month period: a population based study.

Authors:  Janet M Y Cheung; Denise C Jarrin; Simon Beaulieu-Bonneau; Hans Ivers; Geneviève Morin; Charles M Morin
Journal:  Sleep       Date:  2021-11-12       Impact factor: 6.313

5.  Benzodiazepine usage and patient preference for alternative therapies: A descriptive study.

Authors:  Fatema-Tun-Naher Sake; Keith Wong; Delwyn J Bartlett; Bandana Saini
Journal:  Health Sci Rep       Date:  2019-02-21

6.  Impact of Pharmacist-Led Cognitive Behavioural Therapy for Chronic Insomnia.

Authors:  Joshua Nurkowski; Habiba Elshorbagy; Katelyn Halpape; Karen Jensen; Darcy A Lamb; Eric Landry; Alfred Remillard; Derek Jorgenson
Journal:  Innov Pharm       Date:  2020-07-31

7.  Lifting lockdown COVID19 restrictions: What can pharmacists do as the world wakes up?

Authors:  Fatemah Ashkanani; Rebecca Richardson; Laura Lindsey; Adam Pattison Rathbone
Journal:  Explor Res Clin Soc Pharm       Date:  2021-06-12

8.  Primary care management of chronic insomnia: a qualitative analysis of the attitudes and experiences of Australian general practitioners.

Authors:  Jenny Haycock; Nicole Grivell; Elizabeth Hoon; Anne Redman; Bandana Saini; Andrew Vakulin; Leon Lack; Nicole Lovato; Alexander Sweetman; Nicholas Zwar; Nigel Stocks; Oliver Frank; Sutapa Mukherjee; Robert Adams; R Doug McEvoy
Journal:  BMC Fam Pract       Date:  2021-07-22       Impact factor: 2.497

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.